| Year |
Citation |
Score |
| 2020 |
Madsen JR, Boyle TP, Neuman MI, Park EH, Tamber MS, Hickey RW, Heuer GG, Zorc JJ, Leonard JR, Leonard JC, Keating R, Chamberlain JM, Frim DM, Zakrzewski P, Klinge P, et al. Diagnostic Accuracy of Non-Invasive Thermal Evaluation of Ventriculoperitoneal Shunt Flow in Shunt Malfunction: A Prospective, Multi-Site, Operator-Blinded Study. Neurosurgery. PMID 32459841 DOI: 10.1093/Neuros/Nyaa128 |
0.627 |
|
| 2007 |
Cadichon SB, Le Hoang M, Wright DA, Curry DJ, Kang U, Frim DM. Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats. Journal of Neurosurgery. 106: 36-40. PMID 17233310 DOI: 10.3171/Ped.2007.106.1.36 |
0.591 |
|
| 2004 |
Curry DJ, Wright DA, Lee RC, Kang UJ, Frim DM. Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats. Journal of Neurosurgery. 101: 91-6. PMID 16206978 DOI: 10.3171/Ped.2004.101.2.0091 |
0.569 |
|
| 2004 |
Curry DJ, Wright DA, Lee RC, Kang UJ, Frim DM. Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner. Neurosurgery. 55: 943-8; discussion 94. PMID 15458603 DOI: 10.1227/01.Neu.0000137890.29862.2C |
0.579 |
|
| 2004 |
Frim DM, Wright DA, Curry DJ, Cromie W, Lee R, Kang UJ. The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain. Neuroreport. 15: 171-4. PMID 15106852 DOI: 10.1097/00001756-200401190-00033 |
0.591 |
|
| 2003 |
Curry DJ, Wright DA, Lee RC, Kang UJ, Frim DM. Synthes Award for Resident Research in Brain and Craniofacial Injury: poloxamer 188 volumetrically decreases neuron loss in the rat model of excitotoxicity in a time-dependent manner. Clinical Neurosurgery. 50: 374-81. PMID 14677453 |
0.544 |
|
| 1999 |
Frim DM, Scott RM. Management of cavernous malformations in the pediatric population. Neurosurgery Clinics of North America. 10: 513-8. PMID 10419575 DOI: 10.1016/S1042-3680(18)30182-7 |
0.385 |
|
| 1998 |
Frim DM, Scott RM, Madsen JR. Surgical management of neonatal hydrocephalus. Neurosurgery Clinics of North America. 9: 105-10. PMID 9405768 DOI: 10.1016/S1042-3680(18)30283-3 |
0.387 |
|
| 1996 |
Frim DM, Zec N, Golden J, Scott RM. Immunohistochemically identifiable tissue plasminogen activator in cavernous angioma: mechanism for re-hemorrhage and lesion growth. Pediatric Neurosurgery. 25: 137-41; discussion 1. PMID 9144712 DOI: 10.1159/000121111 |
0.377 |
|
| 1996 |
Galpern WR, Frim DM, Tatter SB, Altar CA, Beal MF, Isacson O. Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplantation. 5: 225-32. PMID 8689033 DOI: 10.1016/0963-6897(95)02030-6 |
0.616 |
|
| 1996 |
Galpern WR, Frim DM, Tatter SB, Altar CA, Beal MF, Isacson O. Cell-Mediated Delivery of Brain-Derived Neurotrophic Factor Enhances Dopamine Levels in an Mpp+ Rat Model of Substantia Nigra Degeneration Cell Transplantation. 5: 225-232. DOI: 10.1177/096368979600500211 |
0.577 |
|
| 1995 |
Isacson O, Frim DM, Galpern WR, Tatter SB, Breakefield XO, Schumacher JM. Cell-mediated delivery of neurotrophic factors and neuroprotection in the neostriatum and substantia nigra. Restorative Neurology and Neuroscience. 8: 59-61. PMID 21551807 DOI: 10.3233/Rnn-1995-81213 |
0.594 |
|
| 1994 |
Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proceedings of the National Academy of Sciences of the United States of America. 91: 5104-8. PMID 8197193 DOI: 10.1073/Pnas.91.11.5104 |
0.303 |
|
| Show low-probability matches. |